Bionovate Technologies Corp Net Income
| BIIO Stock | USD 0.0001 0.00 0.00% |
Bionovate Technologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Bionovate Technologies Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -95.9 K | -100.7 K | |
| Net Loss | -95.9 K | -100.7 K | |
| Net Loss | -95.9 K | -100.7 K | |
| Net Loss | (0.01) | (0.01) | |
| Net Income Per E B T | 0.85 | 0.65 |
Bionovate | Net Income | Build AI portfolio with Bionovate Stock |
Evaluating Bionovate Technologies's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Bionovate Technologies Corp's fundamental strength.
Latest Bionovate Technologies' Net Income Growth Pattern
Below is the plot of the Net Income of Bionovate Technologies Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bionovate Technologies financial statement analysis. It represents the amount of money remaining after all of Bionovate Technologies Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bionovate Technologies' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionovate Technologies' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (106.54 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Bionovate Net Income Regression Statistics
| Arithmetic Mean | (209,685) | |
| Coefficient Of Variation | (190.65) | |
| Mean Deviation | 193,492 | |
| Median | (106,544) | |
| Standard Deviation | 399,762 | |
| Sample Variance | 159.8B | |
| Range | 1.7M | |
| R-Value | 0.04 | |
| Mean Square Error | 170.2B | |
| R-Squared | 0 | |
| Significance | 0.88 | |
| Slope | 3,088 | |
| Total Sum of Squares | 2.6T |
Bionovate Net Income History
Other Fundumenentals of Bionovate Technologies
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Bionovate Technologies Net Income component correlations
Bionovate Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Bionovate Technologies is extremely important. It helps to project a fair market value of Bionovate Stock properly, considering its historical fundamentals such as Net Income. Since Bionovate Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bionovate Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bionovate Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Bionovate diversify its offerings? Factors like these will boost the valuation of Bionovate Technologies. Projected growth potential of Bionovate fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bionovate Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Bionovate Technologies's market price often diverges from its book value, the accounting figure shown on Bionovate's balance sheet. Smart investors calculate Bionovate Technologies' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bionovate Technologies' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bionovate Technologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bionovate Technologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bionovate Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bionovate Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bionovate Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bionovate Technologies.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Bionovate Technologies on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Bionovate Technologies Corp or generate 0.0% return on investment in Bionovate Technologies over 90 days. Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots More
Bionovate Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bionovate Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bionovate Technologies Corp upside and downside potential and time the market with a certain degree of confidence.
Bionovate Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bionovate Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bionovate Technologies' standard deviation. In reality, there are many statistical measures that can use Bionovate Technologies historical prices to predict the future Bionovate Technologies' volatility.Bionovate Technologies Backtested Returns
We have found three technical indicators for Bionovate Technologies Corp, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bionovate Technologies are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Bionovate Technologies Corp has perfect predictability. Overlapping area represents the amount of predictability between Bionovate Technologies time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bionovate Technologies price movement. The serial correlation of 1.0 indicates that 100.0% of current Bionovate Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Bionovate Technologies Corp reported net income of (106,544). This is 100.03% lower than that of the Health Care Equipment & Supplies sector and 100.04% lower than that of the Health Care industry. The net income for all United States stocks is 100.02% higher than that of the company.
Bionovate Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionovate Technologies' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bionovate Technologies could also be used in its relative valuation, which is a method of valuing Bionovate Technologies by comparing valuation metrics of similar companies.Bionovate Technologies is currently under evaluation in net income category among its peers.
Bionovate Fundamentals
| Current Valuation | 238.3 K | ||||
| Shares Outstanding | 7.75 M | ||||
| Shares Owned By Insiders | 49.00 % | ||||
| Price To Earning | 0.05 X | ||||
| EBITDA | (45.61 K) | ||||
| Net Income | (106.54 K) | ||||
| Total Debt | 237.38 K | ||||
| Book Value Per Share | (0.07) X | ||||
| Beta | 28.6 | ||||
| Market Capitalization | 775 | ||||
| Retained Earnings | (2.8 M) | ||||
| Working Capital | (503.21 K) |
About Bionovate Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionovate Technologies Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionovate Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionovate Technologies Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bionovate Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionovate Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionovate Technologies will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Bionovate Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionovate Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionovate Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionovate Technologies Corp to buy it.
The correlation of Bionovate Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionovate Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionovate Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionovate Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Health Care Equipment & Supplies sector continue expanding? Could Bionovate diversify its offerings? Factors like these will boost the valuation of Bionovate Technologies. Projected growth potential of Bionovate fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bionovate Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Bionovate Technologies's market price often diverges from its book value, the accounting figure shown on Bionovate's balance sheet. Smart investors calculate Bionovate Technologies' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bionovate Technologies' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bionovate Technologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bionovate Technologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bionovate Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.